TLSA — Tiziana Life Sciences Ltd

—
Nasdaq · Health Care · Pharmaceuticals · CIK 1723069 ·
Last close
$0.65
Market Cap
$82.46M
52W High
$1.90
52W Low
$0.55
ADV30
588,126
Next earnings
—

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGross profitOp incomeNet incomeAssetsCashLiabilities
Jun 2026 — — — — 11,660,000 3,178,000 14,407,000
Dec 2025 — — — — 11,495,000 4,010,000 11,443,000

Balance + Analyst (yfinance extras)

Retained Earnings
$-175,496,000
Inventory
—
Receivables
$6,259,000
ST Investments
—
EBIT TTM
—
Pretax Income TTM
—
Interest Exp TTM
—
Analysts
2

Annual Trend (SEC EDGAR, last 5y)

Revenues vs Net Income (last 5y)

FY endRevenuesOp incomeNet incomeAssetsLiabilitiesEquityOp cash flow
Dec 2025 0 -21,132,000 -18,431,000 11,495,000 11,443,000 52,000 -12,847,000
Dec 2024 0 -15,794,000 -11,863,000 11,284,000 7,348,000 3,936,000 -1,526,000
Dec 2023 0 -17,984,000 -17,691,000 12,184,000 6,648,000 5,536,000 -15,698,000
Dec 2022 0 -14,586,000 -15,397,000 26,477,000 6,906,000 19,571,000 -19,615,000
Dec 2021 — — — — — — —

TTM Snapshot

Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
—
Forward EPS
$-0.20

Peers — same industry

TickerNameMarket CapLastDaily %
RLYB Rallybio Corp $82.32M $15.29 —
ZOMDF Zomedica Corp. $83.30M $0.09 —
RACC Research Alliance Corp III $78.68M $10.12 —
DERM Journey Medical Corp $86.70M $3.90 —
RVRC Revium Rx. $86.84M $1.43 —

News headlines (Yahoo Finance, 1h cache)

Tiziana Life Sciences to Present at the Jefferies Global Healthcare Conference 2026 in London
2026-11-12 13:00 · Yahoo
Tiziana’s nasal foralumab reduces microglial activation in progressive MS trial
2026-11-09 19:46 · Yahoo
Tiziana KOL Call Highlights Consistency Between Positive Phase 2a INFORM-MS Topline Results and Longer-Term Clinical Benefits Observed in Expanded Access Program for Patients with Non-Active Secondary
2026-11-09 18:30 · Yahoo
Tiziana Life Sciences to advance foralumab partnering talks at BIO-Europe 2026
2026-11-09 14:54 · Yahoo
Tiziana Life Sciences to Present at BIO-Europe 2026 and Host KOL Webcast
2026-11-09 12:00 · Yahoo
Tiziana to Host Investor Call with Key Opinion Leaders to Discuss Positive Phase 2a INFORM-MS Topline Results
2026-11-05 19:00 · Yahoo
Tiziana Life Sciences reports positive phase 2a results for Intranasal Foralumab in MS
2026-11-02 14:48 · Yahoo
Tiziana Announces Positive Topline Results from Phase 2a INFORM-MS Trial of Intranasal Foralumab in Non-Active Secondary Progressive Multiple Sclerosis
2026-11-02 12:00 · Yahoo
Tiziana Management Team to Attend the 10th Joint ACTRIMS-ECTRIMS Meeting in Toronto
2026-10-21 11:00 · Yahoo
Tiziana completes dosing in Phase 2 Alzheimer’s trial of intranasal foralumab
2026-10-16 12:38 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.